|
16 Companies |
|
21 Products |
|
21 Products |
|
17 Mechanisms of Action |
|
0 Trials |
|
174 News |
|
| 1234» |
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney Disease (clinicaltrials.gov) - Dec 22, 2018
P=N/A, N=0, Withdrawn, Sponsor: Lund University
N=100 --> 0 | Trial completion date: Aug 2016 --> Aug 2018 | Enrolling by invitation --> Withdrawn | Trial primary completion date: May 2014 --> May 2017
- | Trial completion, Preclinical: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Nov 6, 2018
P=N/A, N=569, Completed, Sponsor: Igenomix
N=100 --> 0 | Trial completion date: Aug 2016 --> Aug 2018 | Enrolling by invitation --> Withdrawn | Trial primary completion date: May 2014 --> May 2017 Active, not recruiting --> Completed
- | Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
Enrollment change, Trial termination: Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (clinicaltrials.gov) - Sep 14, 2018
P=N/A, N=20, Terminated, Sponsor: St. Olavs Hospital
Active, not recruiting --> Completed N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired
- | Trial completion, Preclinical, Enrollment change, Trial completion date: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Sep 12, 2018
P=N/A, N=323, Completed, Sponsor: Reproductive Medicine Associates of New Jersey
N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired Active, not recruiting --> Completed | N=600 --> 323 | Trial completion date: Dec 2018 --> Jul 2018
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=66, Terminated, Sponsor: IVI Sevilla
Active, not recruiting --> Completed | N=600 --> 323 | Trial completion date: Dec 2018 --> Jul 2018 N=200 --> 66 | Trial completion date: Jun 2018 --> Nov 2016 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Nov 2016; Low recruitment
- | Preclinical, Trial completion date, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Jul 10, 2018
P=N/A, N=546, Active, not recruiting, Sponsor: Igenomix
N=200 --> 66 | Trial completion date: Jun 2018 --> Nov 2016 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Nov 2016; Low recruitment Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018
- | Phase classification, Preclinical, Enrollment change: Human Sperm Binding to Transgenic Mouse Eggs (clinicaltrials.gov) - Apr 6, 2018
P, N=13, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018 Phase classification: P=N/A --> P | N=40 --> 13
- | Phase classification: Comparison Between Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) And Intra Cytoplasmic Sperm Injection (ICSI) Techniques With Eggs Donated (clinicaltrials.gov) - Apr 4, 2018
P, N=25, Completed, Sponsor: IVI Madrid
Phase classification: P=N/A --> P | N=40 --> 13 Phase classification: P=N/A --> P
- | Trial termination: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=60, Terminated, Sponsor: IVI Madrid
Phase classification: P=N/A --> P Suspended --> Terminated; Because we don´t have the necessary technology anymore
- | Phase classification, Preclinical, Trial completion date, Trial primary completion date: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Mar 26, 2018
P, N=600, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Suspended --> Terminated; Because we don´t have the necessary technology anymore Phase classification: P=N/A --> P | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Jul 2018
- | Trial completion: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=170, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Phase classification: P=N/A --> P | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Jul 2018 Active, not recruiting --> Completed
- | Trial completion, Surgery, Bariatric surgery: BARIASPERM: Bariatric Surgery and Sperm Quality (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=46, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Utrogestan (progesterone) / Besins Healthcare
Trial completion, Preclinical: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=212, Completed, Sponsor: Universitair Ziekenhuis Brussel
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial primary completion date: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=60, Suspended, Sponsor: IVI Madrid
Recruiting --> Completed Trial primary completion date: Dec 2017 --> Feb 2018
- | Trial completion: Effect of Sorting of Apoptotic Spermatozoa on the Outcome of Assisted Reproduction (clinicaltrials.gov) - Dec 12, 2017
P=N/A, N=100, Completed, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Dec 2017 --> Feb 2018 Active, not recruiting --> Completed
- | Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=200, Recruiting, Sponsor: IVI Sevilla
Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Jun 2018
- || Preclinical, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=546, Active, not recruiting, Sponsor: Igenomix
Trial primary completion date: Jun 2017 --> Jun 2018 Trial primary completion date: Oct 2017 --> Apr 2018
- || Enrollment closed, Preclinical: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Nov 1, 2017
P=N/A, N=546, Active, not recruiting, Sponsor: Igenomix
Trial primary completion date: Oct 2017 --> Apr 2018 Recruiting --> Active, not recruiting
- | Trial completion, Enrollment change: Effects of PGS in Infertile Female Patients With RPL (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=189, Completed, Sponsor: ShangHai Ji Ai Genetics & IVF Institute
Recruiting --> Active, not recruiting Recruiting --> Completed | N=240 --> 189
- | Enrollment closed, Preclinical: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Jul 2, 2017
P=N/A, N=600, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Recruiting --> Completed | N=240 --> 189 Enrolling by invitation --> Active, not recruiting
- | Utrogestan (progesterone) / Besins Healthcare
Preclinical, Trial primary completion date: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - May 4, 2017
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
Enrolling by invitation --> Active, not recruiting Trial primary completion date: Dec 2016 --> Dec 2017
- | Enrollment closed, Enrollment change, Trial primary completion date: Effect of Sorting of Apoptotic Spermatozoa on the Outcome of Assisted Reproduction (clinicaltrials.gov) - May 1, 2017
P=N/A, N=100, Active, not recruiting, Sponsor: University Hospital, Basel, Switzerland
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2015 --> Jan 2017
- | Preclinical, Trial primary completion date: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Mar 17, 2017
P=N/A, N=600, Enrolling by invitation, Sponsor: Reproductive Medicine Associates of New Jersey
Recruiting --> Active, not recruiting | N=200 --> 100 | Trial primary completion date: Dec 2015 --> Jan 2017 Trial primary completion date: Mar 2017 --> Dec 2017
- || Preclinical, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Mar 7, 2017
P=N/A, N=546, Recruiting, Sponsor: Igenomix
Trial primary completion date: Mar 2017 --> Dec 2017 Trial primary completion date: Oct 2016 --> Oct 2017
- | Trial suspension: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=60, Suspended, Sponsor: IVI Madrid
Trial primary completion date: Oct 2016 --> Oct 2017 Active, not recruiting --> Suspended
- cabergoline / Generic mfg.
Phase classification: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Feb 12, 2017
P=N/A, N=300, Completed, Sponsor: Cairo University
Active, not recruiting --> Suspended Phase classification: P3 --> P=N/A
- Trial completion: VATES: Relationship Between Sperm Head Vacuoles and Sperm DNA Alterations in Infertile Men (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=200, Completed, Sponsor: University Hospital, Rouen
Phase classification: P3 --> P=N/A Recruiting --> Completed
- Suprefact (buserelin acetate) / Sanofi
Preclinical, Enrollment change, Trial termination, Trial primary completion date: Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles (clinicaltrials.gov) - Dec 23, 2016
P4, N=194, Terminated, Sponsor: Andros Day Surgery Clinic
Recruiting --> Completed N=360 --> 194 | Recruiting --> Terminated | Trial primary completion date: Mar 2015 --> Jul 2016; Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis
- | Trial completion, Preclinical, Biopsy: A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy (clinicaltrials.gov) - Nov 22, 2016
P2/3, N=160, Completed, Sponsor: Nottingham University Hospitals NHS Trust
N=360 --> 194 | Recruiting --> Terminated | Trial primary completion date: Mar 2015 --> Jul 2016; Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis Recruiting --> Completed
- Utrogestan (progesterone) / Besins Healthcare
Preclinical, Trial primary completion date: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
Recruiting --> Completed Trial primary completion date: Sep 2016 --> Dec 2016
- Trial completion, Enrollment change: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Sep 8, 2016
P1, N=6, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Sep 2016 --> Dec 2016 Recruiting --> Completed | N=15 --> 6
- Preclinical, Trial primary completion date: Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility (clinicaltrials.gov) - Jul 30, 2016
P=N/A, N=300, Completed, Sponsor: Cairo University
Recruiting --> Completed | N=15 --> 6 Trial primary completion date: Feb 2015 --> Jul 2016
- Enrollment closed, Trial primary completion date: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Jul 7, 2016
P=N/A, N=170, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Feb 2015 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016
- | Trial completion, Enrollment change: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Jun 10, 2016
P3, N=162, Completed, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016 Active, not recruiting --> Completed | N=368 --> 162
- | Trial completion, Phase classification: Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial (clinicaltrials.gov) - Jun 10, 2016
P2/3, N=307, Completed, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Completed | N=368 --> 162 Active, not recruiting --> Completed | Phase classification: P4 --> P2/3
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Enrollment change, Trial withdrawal: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (clinicaltrials.gov) - May 26, 2016
P=N/A, N=0, Withdrawn, Sponsor: Antalya IVF
Active, not recruiting --> Completed | Phase classification: P4 --> P2/3 N=800 --> 0 | Recruiting --> Withdrawn
- || Preclinical, Enrollment change: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - May 25, 2016
P=N/A, N=546, Recruiting, Sponsor: Igenomix
N=800 --> 0 | Recruiting --> Withdrawn N=2442 --> 546
- Utrogestan (progesterone) / Besins Healthcare
Preclinical, Trial primary completion date: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - May 25, 2016
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
N=2442 --> 546 Trial primary completion date: Mar 2016 --> Sep 2016
- Trial primary completion date: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Apr 7, 2016
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Mar 2016 --> Sep 2016 Trial primary completion date: Feb 2016 --> Jul 2016
- clomifene citrate / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm (clinicaltrials.gov) - Mar 14, 2016
P=N/A, N=21, Completed, Sponsor: University Hospital, Ghent
Trial primary completion date: Feb 2016 --> Jul 2016 Recruiting --> Completed | N=100 --> 21 | Trial primary completion date: Dec 2015 --> Mar 2016
- Enrollment closed, Trial primary completion date: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=60, Active, not recruiting, Sponsor: IVI Madrid
Recruiting --> Completed | N=100 --> 21 | Trial primary completion date: Dec 2015 --> Mar 2016 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2017
- enoxaparin sodium / Generic mfg.
Enrollment change: Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI) (clinicaltrials.gov) - Feb 18, 2016
P1, N=120, Completed, Sponsor: The Egyptian IVF-ET Center
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2017 N=40 --> 120
- Trial completion: SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=60, Completed, Sponsor: Federal University of São Paulo
N=40 --> 120 Recruiting --> Completed
- Trial primary completion date: VATES: Relationship Between Sperm Head Vacuoles and Sperm DNA Alterations in Infertile Men (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=200, Recruiting, Sponsor: University Hospital, Rouen
Recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Jan 19, 2016
P=N/A, N=200, Recruiting, Sponsor: IVI Sevilla
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jan 2016 --> May 2017
- Utrogestan (progesterone) / Besins Healthcare
Preclinical, Trial primary completion date: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
Trial primary completion date: Jan 2016 --> May 2017 Trial primary completion date: Dec 2015 --> Mar 2016
- || Preclinical, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=2442, Recruiting, Sponsor: Igenomix
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Oct 2015 --> Oct 2016
- | Enrollment closed, Trial primary completion date: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Oct 1, 2015
P3, N=368, Active, not recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: Oct 2015 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Feb 2016
- Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Aug 26, 2015
P=N/A, N=200, Recruiting, Sponsor: IVI Sevilla
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Feb 2016 Trial primary completion date: May 2015 --> Jan 2016
- | cabergoline / Generic mfg.
Trial completion: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Aug 11, 2015
P3, N=300, Completed, Sponsor: Cairo University
Trial primary completion date: May 2015 --> Jan 2016 Active, not recruiting --> Completed